iiinova — where your digital self keeps evolving

DECISION Horizon2020 @decision4liver.bsky.social · 05/08/2026

🆕publication in nature communications! Blood #multiomics revealed molecular networks linking lipid mediators, mitochondrial dysfunction and inflammation with progression to #ACLF and short-term mortality. 🔓 www.nature.com/articles/s41... #Hepatology #LiverSky

021

DECISION Horizon2020 @decision4liver.bsky.social · 23/06/2026

🎉 DECISION video series complete! 💯 Explore short explainers on #cirrhosis, #ACLF, immune dysfunction, epigenetics, extracellular vesicles, single-cell technologies, and MASH research. 🎥 Full playlist: www.youtube.com/playlist?lis... #LiverDisease #SciComm

021

DECISION Horizon2020 @decision4liver.bsky.social · 02/06/2026

What happens before cirrhosis patients suddenly deteriorate? 🪫 Single-cell analysis reveals that monocytes lose energy before organ failure, a signal linked to infections, disease progression, and survival. 🎥 Watch: youtu.be/D1aH-RC6DsM #LiverSky #cirrhosis #liverdisease

022

DECISION Horizon2020 @decision4liver.bsky.social · 30/05/2026

Closing out at #EASLCongress! @rautoupe.bsky.social co-chairs a meet-the-expert session on #liquidbiopsy strategies for #liverdiseases Key questions • What works now and which variables matter? • Where's the near-term value? • What mistakes should we avoid? #EASL2026 @hopitalbeaujon.bsky.social

031

DECISION Horizon2020 @decision4liver.bsky.social · 29/05/2026

Congrats to Juan Bañares (@vhir.bsky.social) for winning this year's EASL Daniel Alagille Award 🙌 🙌Two-year fellowship 🙌 25k funding Prof. Alagille (1925–2005), French paediatric hepatologist, named the Alagille Syndrome & contributed tremendously to the field. @easlnews.bsky.social #EASLCongress

031

DECISION Horizon2020 @decision4liver.bsky.social · 28/05/2026

DECISION member Carlo Alessandria (Università degli Studi di Torino) was part of today's General Session I and contributed a talk on Transjugular intrahepatic portosystemic shunt for refractory hepatic hydrothorax in #cirrhosis: a multicenter European study #EASLCongress #EASL2026 #Hepatology

021

DECISION Horizon2020 @decision4liver.bsky.social · 28/05/2026

We are thrilled to congratulate Prof. Paolo Angeli on winning the 2026 EASL Recognition Award. His scientific contributions, leadership, and clinical excellence set a remarkable standard for the field. Congratulations, Prof. Angeli! @unipd.bsky.social @easlnews.bsky.social #EASL2026

032

Reposted by DECISION Horizon2020

concentris research management gmbh @concentris.bsky.social · 28/05/2026

📢 Full house at the EF CLIF Networking Session today at #EASLCongress here in their local Barcelona 😎 An exciting new initiative is a new #MasterProgramme, starting in Fall 2026🎓 #cirrhosis #ACLF #LiverFailure #EASL2026 @decision4liver.bsky.social @microb-predict.bsky.social @a-tango.bsky.social

054

DECISION Horizon2020 @decision4liver.bsky.social · 27/05/2026

Final session of the day, but an important one nonetheless: Raj Mookerjee (@ucl.ac.uk) presents 'Connected patients (Wearables, implantable sensors, remote follow-up)', during the Postgrad Course: Diagnostics in liver diseases - Shaping the Future #EASL2026 #wearabletech #liverdisease #hepatology

032

DECISION Horizon2020 @decision4liver.bsky.social · 27/05/2026

📱 Remote patient monitoring reduced 90-day liver-related hospitalizations in patients with acutely decompensated cirrhosis. #POSTER TOP-469-YI by Alberto Calleri et al. #EASL2026 #DigitalHealth #Cirrhosis

032

DECISION Horizon2020 @decision4liver.bsky.social · 27/05/2026

In the co-session 'Patient/provider communication', @korenjak.bsky.social (president of @europeliver.bsky.social) stresses three vital in this communication relationship: ⏳ Time 📍Point-of-view 💬Miscommunication @microb-predict.bsky.social @a-tango.bsky.social #EASL2026 #EASLCongress

085

DECISION Horizon2020 @decision4liver.bsky.social · 27/05/2026

🧪 Baseline serum albumin may help identify which patients with cirrhosis benefit most from long-term albumin therapy. #POSTER TOP-455-YI by Enrico Pompili et al. #EASL2026 #Cirrhosis #Hepatology

022

DECISION Horizon2020 @decision4liver.bsky.social · 27/05/2026

Full house at the Postgraduate Course: Diagnostics in liver diseases - Advanced chronic liver disease! Joan Genesca (@vhir.bsky.social) co-presents 'From cirrhosis to #cACLD through modern diagnostics' with Prodromos Hytiroglou. cACLD = compensated Advanced Chronic Liver Disease #EASL2026

032

DECISION Horizon2020 @decision4liver.bsky.social · 27/05/2026

Continuing our networking programme with Estefania Huergo from @navarrabiomed.bsky.social, who presents about epigenomics on patients with acute decompensated cirrhosis #EASL2026 #epigenomics @easlnews.bsky.social

032

DECISION Horizon2020 @decision4liver.bsky.social · 27/05/2026

We're ready to welcome y'all at the DECISION networking session at the cirrhosis & complications track hub at #EASL2026! 🙌 First things first: To set the scene, project coordinator @rautoupe.bsky.social delivers a very brief intro to the DECISION project. #decompensatedcirrhosis #EASL2026

022

DECISION Horizon2020 @decision4liver.bsky.social · 27/05/2026

Greetings from the DECISION Investigator Meeting at #EASL2026: Study updates and collaborative discussions with Paolo Caraceni & @rautoupe.bsky.social #ClinicalTrials #cirrhosis

022

DECISION Horizon2020 @decision4liver.bsky.social · 21/05/2026

#EASL2026 is right around the corner!✨ Also, join our Networking Session and meet Pierre-Emmanuel Rautou, Estefanía Huergo, and Frank Uschner, who will present some exciting new DECISION research. 📍 Cirrhosis & Complications Track Hub 📆 Wednesday, 27 May 🕜 13:45 - 14:15h See you in Barcelona 🪭!

010

DECISION Horizon2020 @decision4liver.bsky.social · 23/04/2026

Why do some cirrhosis patients suddenly deteriorate? #DNAmethylation changes are linked to worse outcomes in acute decompensation, pointing to a key role of #epigenetic regulation in disease progression. 🎥 Watch the explainer: youtu.be/yzTTzx68Sq8 @europeliver.bsky.social

063

DECISION Horizon2020 @decision4liver.bsky.social · 12/03/2026

Therapeutic options for MASLD & MASH remain limited. A new standardized rapid animal model reproduces key features of metabolic liver disease within ~8 weeks, supporting faster #preclinical development. 🎥 Watch the video: youtu.be/n-YC_Dpko2A @frankuschner.bsky.social #LiverSky #Hepatology

000

DECISION Horizon2020 @decision4liver.bsky.social · 03/03/2026

Acute decompensation of cirrhosis carries high 90-day mortality, but prediction remains challenging. Adding signatures of large #extracellularvesicles may improve scores and prediction. 🎥 youtu.be/24-STOSjLeY #EFCLIF @rautoupe.bsky.social @easlnews.bsky.social @europeliver.bsky.social #LiverSky

042

DECISION Horizon2020 @decision4liver.bsky.social · 24/02/2026

In this video, we explore how emergency granulopoiesis, the rapid production of immune cells during crisis, becomes dysregulated in liver failure. 🎥 Watch here: youtu.be/ebN14TCLE24 #LiverSky #LiverFailure #LiverDisease #TranslationalResearch

youtu.be

Emergency Granulopoiesis in Liver Failure: When the Immune System Goes into Chaos

YouTube video by concentris research management

011

DECISION Horizon2020 @decision4liver.bsky.social · 15/01/2026

📺New masterclass! ‘Data repositories & their access and publication rights’ covers the history of databases, an overview of repositories used in DECISION & provides a hands-on recipe on how to make the best out of different types of data ⏯️ youtu.be/aoA0WC1yaqs #bioinformatics

youtu.be

Data repositories and their access and publication rights | Masterclass in bioinformatics

YouTube video by concentris research management

021

DECISION Horizon2020 @decision4liver.bsky.social · 16/12/2025

DECISION's Year-in-Review2️⃣0️⃣2️⃣5️⃣ 💙Networking session at EASL2025 🩵New publication on maladaptive emergency granulopoiesis 💙Met at Final General Assembly in Bologna 🩵Released 3 high-level lectures We look forward to continuing our collaboration in 2026, finishing strong, and maximizing our impact 💪

000

DECISION Horizon2020 @decision4liver.bsky.social · 09/12/2025

New keynote out now! 🌟 Prof. Rubén Francés explains how LSECtin shapes immune tolerance and inflammation in advanced chronic liver disease. Watch here: www.youtube.com/watch?v=pY9H... #LiverSky #cirrhosis #inflammation

youtube.com

The Role of LSECtin in Regulating Inflammation in Advanced Chronic Liver Disease | DECISION Keynote

YouTube video by concentris research management

000

DECISION Horizon2020 @decision4liver.bsky.social · 10/10/2025

That’s a wrap on our final DECISION GA! From COMBAT & PROSPECT updates to forward-looking discussions and feedback, we’re proud of our shared achievements and motivated to keep advancing ACLF & decompensated cirrhosis research together. #LiverSky

000

DECISION Horizon2020 @decision4liver.bsky.social · 09/10/2025

Our final GA is a look back and forward - from major scientific milestones to future discoveries! After a keynote by Prof. Rubén Francés, partners shared results on omics integration, biomarkers & systems medicine - and closed today with a masterclass on data repositories. #cirrhosis

000

DECISION Horizon2020 @decision4liver.bsky.social · 24/09/2025

The latest DECISION Masterclass is live! 💡 Clinical Bioinformatics – It’s More Than Pressing a Button with Núria Planell, Cristina Sanchez & David Gomez-Cabrero. Watch here: youtu.be/UBm1_JGhw6M #Bioinformatics #ClinicalResearch #ACLF

020

DECISION Horizon2020 @decision4liver.bsky.social · 28/07/2025

Today is #WorldHepatitisDay! We spotlight two DECISION partners deeply committed to #liverhealth: 🔬 @easlnews.bsky.social – advancing #hepatology research 🧡 @europeliver.bsky.social – amplifying the voice of liver patients Together, we work toward a healthier future beyond ACLF. #Cirrhosis

043

DECISION Horizon2020 @decision4liver.bsky.social · 26/06/2025

🎥 New keynote online! Prof. Richard Moreau, Director of #EFCLIF, explores immune dysfunction in AD & #ACLF and suggests a common mechanism behind inflammation & immune deficiency. Watch now 👉 youtu.be/KWoUbTsNjQM #LiverSky #Hepatology

030

DECISION Horizon2020 @decision4liver.bsky.social · 17/06/2025

🎉 Exciting news: We’ve surpassed 500 followers on @linkedin.com! Follow us there for updates on trials, science, and more 👉 www.linkedin.com/company/deci... #ClinicalResearch #DECISIONproject

010

DECISION Horizon2020 @decision4liver.bsky.social · 20/05/2025

It’s #ClinicalTrialsDay! At DECISION, we’re proud of our COMBAT & PROSPECT trials advancing care in decompensated cirrhosis. 💡COMBAT Q&A videos in multiple languages help engage patients ➡️ www.youtube.com/playlist?lis... Thanks to all who make our trials possible! #LiverResearch

000

Reposted by DECISION Horizon2020

concentris research management gmbh @concentris.bsky.social · 10/05/2025

✨ #PosterTour today at #EASLCongress 2025: All our 3 Horizon2020 #LiverResearch projects in 1 session! Topic: #Cirrhosis & #PortalHypertension Chair: Maria Papp 💡 Big moments: #AMMON-OHE model for post-#TIPS #encephalopathy (Rajiv Jalan) #Terlipressin response in AKI-HRS w/ CKD (Frank Uschner)

064

DECISION Horizon2020 @decision4liver.bsky.social · 10/05/2025

Clinical trajectories of patients with cirrhosis and ascites receiving long-term albumin #POSTER SAT-145-YI by Enrico Pompili (UNIBO) proposes a personalized management approach for patients with cirrhosis and ascites, based on real-world data from long-term albumin therapy. #EASL2025

041

DECISION Horizon2020 @decision4liver.bsky.social · 10/05/2025

🩺 Impact of diabetes mellitus on clinical outcomes in patients with acutely decompensated cirrhosis #E_POSTER SAT-184-YI by Mimma Bonomo (UNITO) explores how coexisting diabetes mellitus affects prognosis in patients hospitalized with acute decompensation of cirrhosis. #EASL2025

061

DECISION Horizon2020 @decision4liver.bsky.social · 10/05/2025

🦠The recovery failure of fecal microbiota diversity in patients after liver transplant is associated with a complicated postoperative course #POSTER SAT-518 by @beccsipollsi.bsky.social from @rwth.bsky.social at #EASL2025 @brunslab.bsky.social @easlnews.bsky.social

1134

DECISION Horizon2020 @decision4liver.bsky.social · 10/05/2025

🧪 Acute kidney disease in acutely decompensated cirrhosis: impact on clinical outcomes #POSTER SAT-122-YI by Alberto Calleri (UNITO) examines how acute kidney disease affects outcomes in patients with acutely decompensated cirrhosis. 📅 Presented at #EASLCongress | #EASL2025 @easlnews.bsky.social

062

DECISION Horizon2020 @decision4liver.bsky.social · 10/05/2025

❤️ Cardiac performance is impaired in patients with proven alcohol-related hepatitis and predicts 3-month mortality in this patient population #POSTER SAT-503-YI by Pierre-Emmanuel Rautou (@inserm.fr, APHP, EF CLIF) 📅 Presented at the #EASLCongress | #EASL2025 @easlnews.bsky.social

094

DECISION Horizon2020 @decision4liver.bsky.social · 10/05/2025

Back in the Abstract Session: Theresa Wirtz presents her scRNA-seq work on monocyte subsets and ACLF risk. @rwth.bsky.social @brunslab.bsky.social @easlnews.bsky.social #Cirrhosis #ACLF #EASL2025"

095

DECISION Horizon2020 @decision4liver.bsky.social · 10/05/2025

Estefania Huergo presents methylation data in AD patients, selected as best Young Investigator abstract in Basic Science at #EASL2025 - Congrats! 🎉 @navarrabiomed.bsky.social @easlnews.bsky.social #Epigenetics #LiverResearch

093

DECISION Horizon2020 @decision4liver.bsky.social · 10/05/2025

Javier Fernandez (FCRB) is giving the hepatologist perspective on management of MDR infections in cirrhosis as part of the EASL/ESCMID Symposium: MDR infections - a challenge in decompensated cirrhosis at #EASL2025 #LiverDisease #Cirrhosis #Hepatology @easlnews.bsky.social

170

DECISION Horizon2020 @decision4liver.bsky.social · 10/05/2025

Is the etiological work-up of #PSVD a one-size-fits-all? DECISION consortium member Lucile Moga from APHP takes part in EASL/ VALDIG's session on "Do's and Don'ts in the management of Porto-Sinusoidal Vascular Disease". #EASLCongress #EASL2025 #LiverResearch @easlnews.bsky.social

071

DECISION Horizon2020 @decision4liver.bsky.social · 09/05/2025

How do you build&lead a successful research team? The next generation of PIs learned straight from the best in today's workshop “How to Start a Research Group: From Postdoc to PI" as @rautoupe.bsky.social shared practical insights on building&maintaining a high-performing team. @inserm.fr #EASL2025

083

DECISION Horizon2020 @decision4liver.bsky.social · 09/05/2025

DECISION consortium member Sophie Lotersztajn from the French research institute @inserm.fr at a late-afternoon abstract session today at #EASLCongress in Amsterdam, the Netherlands, about #fibrosis, #hepatocyte and #liver #regeneration. 🩺 #EASL2025 @easlnews.bsky.social

051

DECISION Horizon2020 @decision4liver.bsky.social · 09/05/2025

🔬 #POSTER FRI-222 by Thierry Gustot (EF CLIF) proposes one-week criteria to assess the appropriateness of continuing intensive care in ACLF patients who are not candidates for liver transplantation. #EASL2025 @easlnews.bsky.social

071

DECISION Horizon2020 @decision4liver.bsky.social · 09/05/2025

📊 Fibroblast growth factor 19 (FGF-19) predicts transplant free-survival in critically ill patients with acute-onchronic liver failure #POSTER FRI-199 by @beccsipollsi.bsky.social 📅 #EASLCongress | #EASL2025 @easlnews.bsky.social

182